Prophylactic anticonvulsants in patients with primary glioblastoma

Arvin R. Wali, Robert C. Rennert, Sonya G. Wang, Clark C. Chen

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Glioblastoma is the most common form of primary brain cancer in adults and one of the deadliest of human cancers. Seizures are one of the most frequent presentations of glioblastoma. The use of anti-epileptic drugs (AEDs) in glioblastoma patients suffering from seizures is well accepted. However, the role of long-term AED use in patients with glioblastoma without a history of seizures is controversial. Here, we performed a review of the literature to identify studies that examined the use of AEDs in seizure-free glioblastoma patients. We identified one randomized controlled study suggesting no clinical benefit of seizure prophylaxis in this population. Three of the four retrospective studies identified in our search recapitulated this finding, while the remaining study suggested a benefit for prophylactic AED use. All identified studies were focused on seizure incidence in the post-operative period, ranging from 1 week to long-term follow up. Implications of these findings are reviewed herein.

Original languageEnglish (US)
Pages (from-to)229-235
Number of pages7
JournalJournal of neuro-oncology
Volume135
Issue number2
DOIs
StatePublished - Nov 1 2017

Fingerprint

Glioblastoma
Anticonvulsants
Seizures
Pharmaceutical Preparations
Brain Neoplasms
Retrospective Studies
Incidence
Population
Neoplasms

Keywords

  • Anti-epileptic drugs
  • Craniotomy
  • Primary cerebral glioblastoma
  • Seizure

Cite this

Prophylactic anticonvulsants in patients with primary glioblastoma. / Wali, Arvin R.; Rennert, Robert C.; Wang, Sonya G.; Chen, Clark C.

In: Journal of neuro-oncology, Vol. 135, No. 2, 01.11.2017, p. 229-235.

Research output: Contribution to journalReview article

@article{44d9281fe61a4ee2b55447ddd90fa3cd,
title = "Prophylactic anticonvulsants in patients with primary glioblastoma",
abstract = "Glioblastoma is the most common form of primary brain cancer in adults and one of the deadliest of human cancers. Seizures are one of the most frequent presentations of glioblastoma. The use of anti-epileptic drugs (AEDs) in glioblastoma patients suffering from seizures is well accepted. However, the role of long-term AED use in patients with glioblastoma without a history of seizures is controversial. Here, we performed a review of the literature to identify studies that examined the use of AEDs in seizure-free glioblastoma patients. We identified one randomized controlled study suggesting no clinical benefit of seizure prophylaxis in this population. Three of the four retrospective studies identified in our search recapitulated this finding, while the remaining study suggested a benefit for prophylactic AED use. All identified studies were focused on seizure incidence in the post-operative period, ranging from 1 week to long-term follow up. Implications of these findings are reviewed herein.",
keywords = "Anti-epileptic drugs, Craniotomy, Primary cerebral glioblastoma, Seizure",
author = "Wali, {Arvin R.} and Rennert, {Robert C.} and Wang, {Sonya G.} and Chen, {Clark C.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1007/s11060-017-2584-8",
language = "English (US)",
volume = "135",
pages = "229--235",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Prophylactic anticonvulsants in patients with primary glioblastoma

AU - Wali, Arvin R.

AU - Rennert, Robert C.

AU - Wang, Sonya G.

AU - Chen, Clark C.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Glioblastoma is the most common form of primary brain cancer in adults and one of the deadliest of human cancers. Seizures are one of the most frequent presentations of glioblastoma. The use of anti-epileptic drugs (AEDs) in glioblastoma patients suffering from seizures is well accepted. However, the role of long-term AED use in patients with glioblastoma without a history of seizures is controversial. Here, we performed a review of the literature to identify studies that examined the use of AEDs in seizure-free glioblastoma patients. We identified one randomized controlled study suggesting no clinical benefit of seizure prophylaxis in this population. Three of the four retrospective studies identified in our search recapitulated this finding, while the remaining study suggested a benefit for prophylactic AED use. All identified studies were focused on seizure incidence in the post-operative period, ranging from 1 week to long-term follow up. Implications of these findings are reviewed herein.

AB - Glioblastoma is the most common form of primary brain cancer in adults and one of the deadliest of human cancers. Seizures are one of the most frequent presentations of glioblastoma. The use of anti-epileptic drugs (AEDs) in glioblastoma patients suffering from seizures is well accepted. However, the role of long-term AED use in patients with glioblastoma without a history of seizures is controversial. Here, we performed a review of the literature to identify studies that examined the use of AEDs in seizure-free glioblastoma patients. We identified one randomized controlled study suggesting no clinical benefit of seizure prophylaxis in this population. Three of the four retrospective studies identified in our search recapitulated this finding, while the remaining study suggested a benefit for prophylactic AED use. All identified studies were focused on seizure incidence in the post-operative period, ranging from 1 week to long-term follow up. Implications of these findings are reviewed herein.

KW - Anti-epileptic drugs

KW - Craniotomy

KW - Primary cerebral glioblastoma

KW - Seizure

UR - http://www.scopus.com/inward/record.url?scp=85026454701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026454701&partnerID=8YFLogxK

U2 - 10.1007/s11060-017-2584-8

DO - 10.1007/s11060-017-2584-8

M3 - Review article

VL - 135

SP - 229

EP - 235

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -